NCT06805994View on ClinicalTrials.gov

Administering NMT to Reestablish Infant Nasal Microbiome Diversity Following Intranasal Mupirocin Treatment

PHASE1RecruitingINTERVENTIONAL
Enrollment

175

Participants

Timeline

Start Date

August 27, 2025

Primary Completion Date

September 1, 2027

Study Completion Date

January 1, 2028

Conditions
Staphylococcal Aureus InfectionMicrobial ColonizationPediatric InfectionS. Aureus ColonizationMicrobial Transplant
Interventions
BIOLOGICAL

Nasal Microbiota Transplant (NMT)

nasal microbiota transplant

BIOLOGICAL

Placebo

Placebo sterile swab

Trial Locations (1)

21287

RECRUITING

Johns Hopkins University, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT06805994 - Administering NMT to Reestablish Infant Nasal Microbiome Diversity Following Intranasal Mupirocin Treatment | Biotech Hunter | Biotech Hunter